On Nov. 13 at the Magee-Womens Summit, Magee-Womens Research Institute (MWRI) awarded the $1 million Magee Prize to a team ...

Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, ...

Positive clinical data with confirmed overall response rate (ORR) = 62.5% (95% CI, 30.4-86.5) and prospective ACR-368 ...

Kuni Foundation and Dr. Kemi Doll are taking on a medical disparity that has deadly consequences for Black women.

Mass spectrometry and machine learning show promise for early cancer detection and prognosis by analyzing metabolic ...

ovarian and endometrial cancer. We also see an increased risk of heart disease, but all of the research to date has ...

To reduce colorectal cancer risk, being active in both the early morning and evening might provide greater benefits than ...

Columnist Anna Jeter explains how reproductive healthcare was ingrained in both her PH treatment plan and her post-transplant ...

Despite significant medical advancements in the oncology space, 30% of patients in the GSK/Harris Poll survey said they never ...

Robert W. Baird analyst Colleen M. Kusy maintained a Buy rating on Karyopharm Therapeutics (KPTI – Research Report) on November 6 and set ...

JMP Securities analyst Silvan Tuerkcan maintained a Buy rating on Acrivon Therapeutics, Inc. (ACRV – Research Report) today and set a ...